Efficacy of Omega-3 Fatty Acid Therapy in Preventing Gastrointestinal Bleeding in Patients With CF-LVAD
Status:
Terminated
Trial end date:
2020-07-15
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy of high-dose fish oil in decreasing rates of
gastrointestinal bleeding in patients with continuous-flow left ventricular assist devices.
Half of the patients without history of bleeding will receive fish oil while the other half
will not. Half of the patients with history of bleeding will receive fish oil while the other
half will not. Markers of angiogenesis and inflammation, as well as changes in the microbiome
will be assessed in each group.